Ben J Glasgow1, Tara A McCannel2. 1. Department of Ophthalmology, Stein Eye Institute, UCLA School of Medicine, Los Angeles, California; Department of Pathology and Laboratory Medicine, Stein Eye Institute, UCLA School of Medicine, Los Angeles, California. Electronic address: bglasgow@mednet.ucla.edu. 2. Department of Ophthalmology, Stein Eye Institute, UCLA School of Medicine, Los Angeles, California.
Abstract
PURPOSE: Prior studies have shown that nuclear reactivity for BRCA1-associated protein-1 (BAP1) yields prognostic information for paraffin-embedded uveal melanomas. Lacking are immunocytochemical studies of BAP1 on fine needle aspiration biopsies of uveal melanoma that correlate with prognosis or other markers of prognosis. Our purpose was to fill this gap. DESIGN: Experimental laboratory study. METHODS: Fine needle aspiration biopsies were performed prospectively on 113 patients with uveal melanomas, garnering limited subsets of cases for comparison. Agreement between immunocytochemistry for BAP1 nuclear staining vs chromosome 3 ploidy analysis and gene expression profiling was assessed by 2 × 2 contingency table analysis. RESULTS: The presence or absence of suppression of nuclear expression of BAP1 was strongly associated (73%, P = .000002) with monosomy and disomy chromosome 3, respectively. BAP1 nuclear expression was also correlated with gene expression profiling. Chromosome 3 ploidy analysis correlated with gene expression profiles. CONCLUSION: When adequate material is obtained, immunocytology using BAP1 is a potentially informative tool for prognostication of uveal melanoma.
PURPOSE: Prior studies have shown that nuclear reactivity for BRCA1-associated protein-1 (BAP1) yields prognostic information for paraffin-embedded uveal melanomas. Lacking are immunocytochemical studies of BAP1 on fine needle aspiration biopsies of uveal melanoma that correlate with prognosis or other markers of prognosis. Our purpose was to fill this gap. DESIGN: Experimental laboratory study. METHODS: Fine needle aspiration biopsies were performed prospectively on 113 patients with uveal melanomas, garnering limited subsets of cases for comparison. Agreement between immunocytochemistry for BAP1 nuclear staining vs chromosome 3 ploidy analysis and gene expression profiling was assessed by 2 × 2 contingency table analysis. RESULTS: The presence or absence of suppression of nuclear expression of BAP1 was strongly associated (73%, P = .000002) with monosomy and disomy chromosome 3, respectively. BAP1 nuclear expression was also correlated with gene expression profiling. Chromosome 3 ploidy analysis correlated with gene expression profiles. CONCLUSION: When adequate material is obtained, immunocytology using BAP1 is a potentially informative tool for prognostication of uveal melanoma.
Authors: J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock Journal: Science Date: 2010-11-04 Impact factor: 47.728
Authors: Johannes A P van de Nes; Jasmin Nelles; Stefan Kreis; Claudia H D Metz; Thomas Hager; Dietmar R Lohmann; Michael Zeschnigk Journal: Am J Surg Pathol Date: 2016-06 Impact factor: 6.394
Authors: Jolanda Vaarwater; Thomas van den Bosch; Hanneke W Mensink; Chantal van Kempen; Rob M Verdijk; Nicole C Naus; Dion Paridaens; Hennie T Brüggenwirth; Emine Kiliç; Annelies de Klein Journal: Melanoma Res Date: 2012-02 Impact factor: 3.599
Authors: Michael A Klufas; Elizabeth Richter; Sujit Itty; Christian Moreno; Colin A McCannel; Tara A McCannel Journal: Ocul Oncol Pathol Date: 2017-06-14
Authors: Christina Herrspiegel; Anders Kvanta; Emma Lardner; Louise Ramsköld Cabaca; Jill Wells; Katarina Bartuma; Stefan Seregard; Gustav Stålhammar Journal: Br J Ophthalmol Date: 2020-06-10 Impact factor: 4.638